Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Clay Beauregard"'
Autor:
Wei Qiu, Qi Sun, Yi Yang, Chirag Patel, Meng Sun, Yue Liu, Kyle Halliwill, Sarah Kim, Rebecca Mathew, Jennifer M Frost, Jennifer A Roth, Domenick Kennedy, Robert T Manguso, Kathleen B Yates, Hakimeh Ebrahimi-Nik, Christina K Baumgartner, Arvin Iracheta-Vellve, Keith M Hamel, Kira Olander, Thomas GR Davis, Kathleen A McGuire, Geoff T Halvorsen, Omar I Avila, Ashwin V Kammula, Audrey J Muscato, Prasanthi Geda, Kelly Klinge, Zhaoming Xiong, Ryan Duggan, Liang Mu, Mitchell D Yeary, James C Patti, Tyler M Balon, Carey Backus, Angeline Chen, Kenton Longenecker, Joseph Klahn, Cara Hrusch, Navasona Krishnan, Charles W Hutchins, Jacqueline Aguado, Marinka Bulic, Payal Tiwari, Kayla J Colvin, Cun Lan Chuong, Ian C Kohnle, Matthew G Rees, Andrew Boghossian, Melissa Ronan, Meng-Ju Wu, Debattama R Sen, Gabriel K Griffin, Nabeel El-Bardeesy, Patricia Trusk, Joshua H Decker, Stacey Fossey, Marcia N Paddock, Elliot P Farney, Clay Beauregard, Philip R Kym
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/11356ff1bf1f4b63ab1324cafa253315
Autor:
SangKon Oh, Gerard Zurawski, Andrew G. Sikora, Sandra Zurawski, Jung-Hee Woo, Clay Beauregard, Sang-Yull Lee, LuAnn Thompson-Snipes, Seunghee Kim-Schulze, Falguni Parikh, Amelia Clark, Lance Oxford, Richard Ouedraogo, Lei Wang, Zhiqing Wang, Chao Gu, Yaming Xue, HyeMee Joo, Dorothée Duluc, Wenjie Yin
Supplementary Materials and Methods: This section includes additional Materials and Methods. Supplementary Figure S1: Specificity and binding ability of αCD40 (12E12) antibody. Supplementary Figure S2. αCD40-HPV16.E6/7 can target CD40 and can thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007840a4f5d42b57304f62303bd0fda6
https://doi.org/10.1158/2326-6066.22538498.v1
https://doi.org/10.1158/2326-6066.22538498.v1
Autor:
SangKon Oh, Gerard Zurawski, Andrew G. Sikora, Sandra Zurawski, Jung-Hee Woo, Clay Beauregard, Sang-Yull Lee, LuAnn Thompson-Snipes, Seunghee Kim-Schulze, Falguni Parikh, Amelia Clark, Lance Oxford, Richard Ouedraogo, Lei Wang, Zhiqing Wang, Chao Gu, Yaming Xue, HyeMee Joo, Dorothée Duluc, Wenjie Yin
Human papillomavirus (HPV), particularly HPV16 and HPV18, can cause cancers in diverse anatomical sites, including the anogenital and oropharyngeal (throat) regions. Therefore, development of safe and clinically effective therapeutic vaccines is an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::734678c2aeadb8db4e768b9966c3a7b9
https://doi.org/10.1158/2326-6066.c.6548798.v1
https://doi.org/10.1158/2326-6066.c.6548798.v1
Autor:
Christina K. Baumgartner, Marcia N. Paddock, Jennifer M. Frost, Keith M. Hamel, Kathleen A. McGuire, Kyle Halliwill, Zhaoming Xiong, Liang Mu, Kelly Klinge, Prasanthi Geda, Jaqueline Aguado, Marinka Bulic, Elliot P. Farney, Kathleen B. Yates, Robert T. Manguso, Clay Beauregard, Philip R. Kym
Publikováno v:
Cancer Research. 82:ND06-ND06
Background: Pharmacologic inhibition of PTPN2 and PTPN1 (PTPN2/N1) represents a novel therapeutic approach in immuno-oncology that augments innate and adaptive immune responses in addition to enhancing tumor cell sensitivity to immune-mediated killin
Autor:
Arvin Iracheta-Vellve, Hakimeh Ebrahimi-Nik, Thomas R. Davis, Kira E. Olander, Sarah Y. Kim, Mitchell D. Yeary, James C. Patti, Ian C. Kohnle, Christina K. Baumgartner, Keith M. Hamel, Kathleen A. McGuire, Cun Lan Chuong, Zhaoming Xiong, Elliot P. Farney, Jennifer M. Frost, Matthew Rees, Andrew Boghossian, Melissa Ronan, Jennifer A. Roth, Todd R. Golub, Gabriel K. Griffin, Clay Beauregard, Philip R. Kym, Kathleen B. Yates, Robert T. Manguso
Publikováno v:
Cancer Research. 82:606-606
Immune checkpoint blockade is effective for a subset of patients across many cancers, but most patients are refractory to current immunotherapies and new approaches are needed to overcome resistance. The protein tyrosine phosphatase PTPN2 is a centra
Autor:
Richard Ouedraogo, Yaming Xue, Chao Gu, Jung Hee Woo, Lei Wang, Wenjie Yin, Lu Ann Thompson-Snipes, Amelia Clark, Seunghee Kim-Schulze, HyeMee Joo, Zhiqing Wang, Clay Beauregard, Sangkon Oh, Dorothée Duluc, Falguni Parikh, Sang Yull Lee, Gerard Zurawski, Lance Oxford, Andrew G. Sikora, Sandra Zurawski
Publikováno v:
Cancer immunology research. 4(10)
Human papillomavirus (HPV), particularly HPV16 and HPV18, can cause cancers in diverse anatomical sites, including the anogenital and oropharyngeal (throat) regions. Therefore, development of safe and clinically effective therapeutic vaccines is an i
Publikováno v:
Transplantation. 81:1577-1582
Background. Murine models of high-risk and low-risk corneal transplantation were used to determine the role of keratocyte apoptosis in the failure of orthotopic allogeneic corneal transplants. Materials and Methods. Normal (low-risk, low-rejecting) a
Publikováno v:
Experimental Eye Research. 77:109-114
Purpose. Inflammation of the lacrimal gland is one of the major causative factors in aqueous tear-deficient dry eye syndrome. Pro-inflammatory cytokine production is upregulated in lacrimal gland autoimmune disease (i.e. Sjogren's syndrome) and is as
Autor:
Jessamee Mellon, Jerry Y. Niederkorn, Elizabeth Mayhew, Christina Stevens, Peter Chen, Clay Beauregard
Publikováno v:
The FASEB Journal. 22
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 23(4)
The topical application of 0.1% olopatadine has been shown to provide significant attenuation of histamine-induced conjunctival vascular permeability (CVP) within 5 min and for as long as 24 h following a topical administration. The duration of the a